The EVLW for Set the Positive End Expiratory Pressure (PEEP) in the Acute Respiratory Distress Syndrome (ARDS)
NCT ID: NCT00714987
Last Updated: 2009-09-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
40 participants
OBSERVATIONAL
2009-01-31
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The set of the PEEP (low or high levels) remains unclear : it seems that some patients need low levels of PEEP whereas anther need high levels; but there is no validated data that can discriminate them.
* We hypothesized that patients with low levels of EVLW ( measured with the Picco® system ) need low level of PEEP to ameliorate their oxygenation ( measured with the PaO2/FiO2 ratio ) whereas patients with high levels of EVLW) need high levels of PEEP.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Hemodynamic Effects of PEEP According to Alveolar Recruitment During the ARDS
NCT05524558
Association Between Driving Transpulmonary Pressure and Extravascular Lung Water in Patients with ARDS
NCT05474196
Trans-pulmonary Pressure in ARDS
NCT02416037
Safety of Low PEEP Maneuvers During ARDS Management
NCT05922969
A Multicenter, Random Control Study :Early Use of Airway Pressure Release Ventilation (APRVplus) Protocol in ARDS
NCT03549910
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1: High level PEEP
No interventions assigned to this group
2: Low level PEEP
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ARDS criteria.
Exclusion Criteria
* chronic right ventricular failure;
* pulmonary embolism;
* tricuspidian valvulopathy;
* history of spontaneous pneumothorax;
* severe emphysema;
* bronchomalacia;
* recent pulmonary surgery;
* BMI\>40;
* Interstitial pulmonary fibrosis;
* End of life;
* Chronic neuromyopathie;
* Recent neurosurgery or intracranian hypertension;
* Pregnancy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Organization: University Hospital, Strasbourg, France
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fady KARA, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Strasbourg, France
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3800
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.